Paper40141002
Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma.
Hao B and 5 others. Exp Hematol Oncol, 2025. Cited by 11 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma. Papers, record 40141002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40141002
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82073090 | National Natural Science Foundation of China | PubMed | ||
| 202303021211220 | Shanxi Province "136" Revitalization Medical Project Construction Funds, Fundamental Research Program of Shanxi Province - Free Exploration Category | PubMed | ||
| 2023M741275 | China Postdoctoral Science Foundation | PubMed | ||
| 2024ZHA NCHI07 | Research and Innovation Team Project for Scientific Breakthroughs at Shanxi Bethune Hospital | PubMed |
Source PubMed
References234
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11847101 | The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. | EMBO J | 2002 | https://conductscience.org/library/papers/11847101 | PubMed |
| 2 | 22007836 | Serum hepatitis B surface antigen levels in the natural history of chronic hepatitis B infection. | Aliment Pharmacol Ther | 2011 | https://conductscience.org/library/papers/22007836 | PubMed |
| 3 | 31446185 | How Do We Determine Whether a Functional Cure for HBV Infection Has Been Achieved? | Clin Gastroenterol Hepatol | 2020 | https://conductscience.org/library/papers/31446185 | PubMed |
| 4 | 26563120 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. | Hepatol Int | 2016 | https://conductscience.org/library/papers/26563120 | PubMed |
| 5 | 31680002 | Niacin analogue, 6-Aminonicotinamide, a novel inhibitor of hepatitis B virus replication and HBsAg production. | EBioMedicine | 2019 | https://conductscience.org/library/papers/31680002 | PubMed |
| 6 | 28983565 | The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. | JAMA Oncol | 2017 | https://conductscience.org/library/papers/28983565 | PubMed |
| 7 | 22459735 | Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape. | J Infect Dis | 2012 | https://conductscience.org/library/papers/22459735 | PubMed |
| 8 | 14633616 | Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. | Am J Pathol | 2003 | https://conductscience.org/library/papers/14633616 | PubMed |
| 9 | 38395437 | HBV integrations reshaping genomic structures promote hepatocellular carcinoma. | Gut | 2024 | https://conductscience.org/library/papers/38395437 | PubMed |
| 10 | 33007418 | Endoplasmic reticulum stress and protein degradation in chronic liver disease. | Pharmacol Res | 2020 | https://conductscience.org/library/papers/33007418 | PubMed |
| 11 | 24810055 | Cab45S inhibits the ER stress-induced IRE1-JNK pathway and apoptosis via GRP78/BiP. | Cell Death Dis | 2014 | https://conductscience.org/library/papers/24810055 | PubMed |
| 12 | 35643206 | Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection. | J Hepatol | 2022 | https://conductscience.org/library/papers/35643206 | PubMed |
| 13 | 19726872 | The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19726872 | PubMed |
| 14 | 26393879 | HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma. | Oncotarget | 2015 | https://conductscience.org/library/papers/26393879 | PubMed |
| 15 | 26877602 | Hepatocellular carcinoma and hepatitis B surface protein. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/26877602 | PubMed |
| 16 | 30177788 | Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model. | Sci Rep | 2018 | https://conductscience.org/library/papers/30177788 | PubMed |
| 17 | 34360777 | Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34360777 | PubMed |
| 18 | 4042421 | Interference of hepatitis B virus surface antigen with natural killer cell function. | Clin Exp Immunol | 1985 | https://conductscience.org/library/papers/4042421 | PubMed |
| 19 | 12270119 | Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes. | Biochem Biophys Res Commun | 2002 | https://conductscience.org/library/papers/12270119 | PubMed |
| 20 | 27276529 | Hepatitis B virus surface protein-induced hPIAS1 transcription requires TAL1, E47, MYOG, NFI, and MAPK signal pathways. | Biol Chem | 2016 | https://conductscience.org/library/papers/27276529 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42944075 | The Role of Viral Pathogens in the Promotion of Epithelial-Mesenchymal Transition and Neoplastic Cell Invasion. | Viruses | 2026 | https://conductscience.org/library/papers/42944075 | PubMed |
| 42623526 | A randomized trial of viral vector and adjuvanted protein HBV therapeutic vaccine in people with chronic hepatitis B on nucleos(t)ide analogs. | Hepatol Commun | 2026 | https://conductscience.org/library/papers/42623526 | PubMed |
| 42594138 | Network pharmacology and molecular simulation study on the multi-target gene regulatory mechanism of Isatis indigotica against hepatic inflammation. | PLoS One | 2026 | https://conductscience.org/library/papers/42594138 | PubMed |
| 42294461 | Current advances and future directions in the management of HBV-related hepatocellular carcinoma. | Gastroenterol Rep (Oxf) | 2026 | https://conductscience.org/library/papers/42294461 | PubMed |
| 42038307 | Protein quality control and antigen presentation in the development of hepatitis B-related hepatocellular carcinoma. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42038307 | PubMed |
| 42014525 | Establishment and characterization of a novel HBV-integrated hepatic sarcomatoid carcinoma cell line. | Hum Cell | 2026 | https://conductscience.org/library/papers/42014525 | PubMed |
| 41754527 | Direct Viral Mechanisms Underlying the Onset of HBV-Related Hepatocellular Carcinoma and Implications for Therapeutic Strategies. | Viruses | 2026 | https://conductscience.org/library/papers/41754527 | PubMed |
| 41350719 | Dual defects in HBsAg antigenicity and secretion caused by the C138R mutation in the S gene trigger occult hepatitis B virus infection. | J Transl Med | 2025 | https://conductscience.org/library/papers/41350719 | PubMed |
| 41174783 | Exploratory analysis of lamivudine legacy and clonal selection of HBs truncation mutants in HBV-related hepatocellular carcinoma. | Infect Agent Cancer | 2025 | https://conductscience.org/library/papers/41174783 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40141002
GET https://conductscience.org/api/papers/v1/40141002/references?page=2